CHNG - CHNG STOCK NEWS

Change Healthcare reported Q4 and fiscal year results ending March 31, 2021, highlighting a total revenue of $855.2 million and a net loss of $13.1 million, or $0.04 per diluted share. Adjusted net income was $134.0 million, yielding $0.42 per diluted share. The company announced a merger with OptumInsight, which has been approved by stockholders. Due to this merger, Change Healthcare will no longer provide financial guidance. Cash flow from operating activities stood at $586.2 million.

Change Healthcare (Nasdaq: CHNG) has launched its new Vaccination Record solution, enhancing access to digital vaccination and testing records for consumers. This fee-free service empowers providers to easily deliver secure records to patients, enabling them to share their vaccination status with authorized parties. Accessible on various devices and designed for convenience, this solution allows for simple verification of vaccination status, supporting consumers in various settings including travel and public events. The service is currently available at over 2,000 pharmacy locations nationwide.

Change Healthcare (Nasdaq: CHNG) is set to disclose its fourth quarter and full year fiscal 2021 financial results on May 26, 2021, after market close. A conference call will follow on May 27, 2021, at 8:00 am ET; however, due to the recent transaction with OptumInsight, no questions will be taken during the call. Investors can access the conference via the company's website, with an on-demand webcast available until May 27, 2022. Change Healthcare aims to enhance the U.S. healthcare system through data-driven solutions that improve outcomes across clinical, financial, and administrative areas.

Change Healthcare (Nasdaq: CHNG) released InterQual® 2021, enhancing its clinical decision support solution with new Medicare criteria modules and updates focused on COVID-19 care, social determinants of health, and telehealth usage. This edition, developed under the leadership of Monique Yohanan, MD, includes significant evidence-based updates to over half of the existing criteria. Notably, more than 500,000 reviews have utilized the InterQual® COVID-19 criteria. The updates aim to assist clinicians in improving patient outcomes through timely intervention and data-driven decision-making.

Change Healthcare Inc. (Nasdaq: CHNG) announced that stockholders overwhelmingly approved the merger with OptumInsight, a subsidiary of UnitedHealth Group, during a special meeting. Out of approximately 222 million shares voted, 99.9% favored the merger agreement. This merger aligns with Change Healthcare's focus on enhancing the U.S. healthcare system through innovative technology and data-driven solutions.

Change Healthcare (Nasdaq: CHNG) has partnered with Amazon Web Services (AWS) to launch a new Data Science as a Service (DSaaS) offering. This service aims to enhance the analysis of healthcare interventions for underserved populations by integrating de-identified claims data with social determinants of health. The DSaaS model automates compliance monitoring and provides tailored analytics solutions, promoting timely patient-level data integration. This initiative can improve healthcare outcomes by addressing inequities tied to social determinants, as highlighted by its application in COVID-19 research at Duke University.

Change Healthcare (Nasdaq: CHNG) has been awarded the 2021 Best in KLAS recognition for its Eligibility & Enrollment Services in the Financial/Revenue Cycle sector, marking its fourth consecutive win. The awards reflect feedback from over 22,000 providers and payers and acknowledge excellence in healthcare IT solutions. Additionally, Change Healthcare Consulting Services received top honors for Payer IT Consulting Services, showcasing its commitment to improving healthcare delivery through innovative technology and customer service.

Change Healthcare (Nasdaq: CHNG) reported its financial results for Q3 FY2021, achieving total revenue of $785.1 million and solutions revenue of $735.3 million. The company reported a net income of $2.2 million, equating to $0.01 per diluted share, and an adjusted net income of $110.1 million or $0.34 per diluted share.

New business initiatives include a partnership with Carnegie Mellon for COVIDcast data, the launch of SDoH Analytics, and a proposed merger with OptumInsight at $25.75 per share. The merger is expected to complete in H2 2021.

Change Healthcare Inc. (Nasdaq: CHNG) is set to announce its third quarter fiscal 2021 financial results on February 3, 2021, after market close. A conference call will follow on February 4, 2021, at 8:00 a.m. ET, although no questions will be taken due to the ongoing transaction with OptumInsight. Change Healthcare focuses on enhancing the healthcare system through its data-driven technology solutions aimed at improving various healthcare outcomes.